INTRODUCTION:
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are fatal neurodegenerative diseases that share clinical and neuropathological features. Furthermore, the most common genetic cause of both FTD and ALS is a GGGGCC (G 4 C 2 ) repeat expansion in the C9orf 72 gene. This repeat expansion leads to several abnormalities, including C9orf72 haploinsufficiency, the accumulation of repeat RNA, and the production of five aggregation-prone proteins composed of repeating dipeptides. However, the contribution of these abnormalities to disease pathogenesis remains unresolved.
RATIONALE: Among the five dipeptide repeat proteins nonconventionally translated from expanded G 4 C 2 repeats, proline-arginine (PR) repeat proteins [poly(PR) proteins] have proven especially toxic in various model systems. Their involvement in C9orf72-associated FTD and ALS (c9FTD/ALS) has nevertheless been questioned because poly(PR) pathology is relatively infrequent in c9FTD/ALS patient brains. Postmortem tissues, however, represent end-stage disease and do not necessarily reflect early events in the disease process. Therefore, we generated mice that express poly(PR) in the brain to evaluate the temporal consequences of its expression in a mammalian in vivo model. More specifically, we engineered mice to express green fluorescent protein (GFP)-conjugated (PR) 50 (a 50-repeat PR protein) or GFP via intracerebroventricular administration of adeno-associated viral vectors and then performed behavioral, pathological, and transcriptomic characterizations of poly(PR) mice in comparison with control GFP mice.
RESULTS:
We found that~60% of poly(PR)-expressing mice died by 4 weeks of age and had significantly decreased brain and body weights at death compared with age-matched GFP control mice. Poly(PR) mice that escaped premature death developed motor and memory impairments, likely as a consequence of their progressive brain atrophy, neuron loss, loss of poly(PR)-positive cells, and gliosis. In investigating the mechanisms by which poly(PR) caused neurodegeneration and functional deficits, we found that poly(PR) localized to heterochromatin (highly condensed regions of transcriptionally silent chromatin) and caused abnormal histone H3 methylation, features that we also detected in brain tissues from patients with c9FTD/ALS. Additionally, we observed aberrations in nuclear lamins and heterochromatin protein 1a (HP1a), key proteins that maintain heterochromatin structure and regulate gene silencing. Nuclear lamina invaginations and decreased HP1a protein expression were seen in poly(PR)-positive cells in poly(PR) mice, and in vitro studies demonstrated that poly(PR) disrupted HP1a liquid phases. Because poly(PR)-induced histone H3 posttranslational modifications, lamin invaginations, and decreased HP1a levels could profoundly affect gene expression, we compared transcriptome profiles between control and poly(PR) mice. As well as analyzing differentially expressed genes, we examined repetitive element expression given that repetitive DNA sequences make up a large portion of heterochromatin and that repetitive elements are substantially up-regulated in the brains of c9FTD/ALS patients. Whereas the majority of differentially expressed genes in poly(PR) mice were down-regulated, repetitive elements were markedly up-regulated, and this up-regulation was accompanied by the accumulation of double-stranded RNA. Furthermore, we confirmed that HP1a depletion caused double-stranded RNA accumulation in human induced pluripotent stem cell-derived neurons and decreased their survival.
CONCLUSION: Our studies provide compelling evidence that, by disrupting HP1a liquid phases, interacting with heterochromatin, and eliciting aberrant histone posttranslational modifications, poly(PR) adversely influences heterochromatin structure. Consequently, repetitive element expression is induced and doublestranded RNA accumulates, contributing to the neurodegeneration seen in patients with c9FTD/ALS. Rescuing histone methylation, lamin, and HP1a abnormalities and/or inhibiting abnormal repetitive element expression may represent promising therapeutic strategies for treating c9FTD/ALS. (1, 2) . The mechanisms by which C9orf 72 G 4 C 2 repeat expansions cause C9orf 72-associated FTD and ALS (c9FTD/ALS) are being extensively investigated. Mounting evidence implicates both loss-of-function and gain-of-function mechanisms in c9FTD/ALS pathogenesis. For instance, loss of C9ORF72 causes immune dysregulation (3, 4) and impairs the autophagy-lysosome pathway (5-9), which may enhance abnormal protein deposition. The accumulation of expanded repeatcontaining transcripts, conversely, is thought to cause toxic gains of function. These transcripts bind several RNA binding proteins and form RNA foci, thus impairing RNA metabolism (10) (11) (12) (13) (14) , nucleocytoplasmic transport (15, 16) , and RNA transport granule function (17) . Moreover, these transcripts produce glycine-alanine (GA), glycineproline (GP), glycine-arginine (GR), prolinearginine (PR), and proline-alanine (PA) dipeptide repeat (DPR) proteins [poly(GA), poly(GP), poly(GR), poly(PR), and poly(PA)] through repeatassociated non-ATG translation (18) (19) (20) (21) (22) . All five DPR proteins form neuronal inclusions in patients with c9FTD/ALS (18) (19) (20) (21) (22) , but studies in cultured cells and neurons, as well as Drosophila, suggest that arginine-rich poly(PR) is the most toxic DPR protein (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Several mechanisms have been ascribed to poly(PR)-induced toxicity, including nucleolar stress (23, 24, 26, 30) and impaired nucleocytoplasmic transport (27, 28) , protein translation (26, 31) , and stress granule dynamics (26, 30, 32) . Although poly(PR) is considered highly toxic, poly(PR) pathology is infrequent in c9FTD/ALS patient brains (19, 20, 33, 34) , raising questions about its contribution to c9FTD/ALS pathogenesis. However, because postmortem tissues represent end-stage disease and do not necessarily reflect early events in the disease process, we generated mice that express poly(PR) in the brain to evaluate the temporal consequences of poly(PR) expression in a mammalian in vivo model.
GFP-(PR) 50 mice developed neurodegeneration and behavioral deficits
We engineered mice to express green fluorescent protein (GFP)-conjugated (PR) 50 (a 50-repeat PR protein) or GFP in the brain via intracerebroventricular administration of adeno-associated virus serotype 1 (AAV1) at postnatal day 0. A codonoptimized vector was used to specifically express GFP-(PR) 50 in the absence of repeat RNA. Consistent with the reported toxicity of poly(PR) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) ,~60% of GFP-(PR) 50 -expressing mice died by 4 weeks of age ( fig. S1A ) and had significantly decreased brain and body weights at death compared with age-matched GFP-expressing control mice ( fig. S1 , B to D). GFP-(PR) 50 mice that escaped premature death were sacrificed at 1 or 3 months of age for more in-depth analyses. These mice developed a progressive decrease in brain weight ( fig. S2A ), and hematoxylin-and eosin-stained brain sections revealed cortical thinning and reduced hippocampal volume in 3-month-old GFP-(PR) 50 mice compared with age-matched GFP mice ( fig. S2B ). With the exception of 3-month-old female mice, no difference in body weight was observed between age-and sex-matched GFP and GFP-(PR) 50 mice ( fig. S2C ).
Given that our gross morphological analysis revealed brain atrophy in GFP-(PR) 50 mice ( fig.  S2B ), we examined the relationship between poly(PR) expression and neuron loss. Immunohistochemical staining showed a predominantly nuclear distribution of poly(PR) in the cortices and cerebellums of 1-and 3-month-old GFP-(PR) 50 mice (Fig. 1A and fig. S3A ). Virtually all poly(PR)-positive cells were immunoreactive for the neuronal markers microtubule-associated protein 2 (MAP2) and NeuN, indicating that the poly(PR) expression was neuronal ( fig. S3B) . Notably, the number of poly(PR)-positive cells in the cortex and cerebellum significantly decreased from 1 to 3 months of age (Fig. 1, A and B, and fig. S3C ). Consistent with these findings, immunoassay and immunoblot analyses showed a significant reduction in poly(PR) levels in 3-month-old GFP-(PR) 50 mice compared with 1-month-old GFP-(PR) 50 mice (Fig. 1C and fig. S3, D and E) . The age-dependent loss of poly(PR)-expressing cells in the cortex and cerebellum was accompanied by an agedependent loss of NeuN-positive cortical neurons (Fig. 1, D and E) and of cerebellar Purkinje cells ( fig. S3, F and G) , suggesting that poly(PR) expression caused cell-autonomous neuron death. Transgene RNA levels were significantly higher in GFP mice than in GFP-(PR) 50 mice, arguing against neuronal loss being caused by high transgene expression ( fig. S3H) .
Inflammation is believed to be a key process in FTD and ALS and is often associated with neurodegeneration. Hence, we examined the brains of mice for reactive astrocytes and microglia. Transcript levels of Gfap, a marker of astrogliosis, were significantly increased in the brains of GFP-(PR) 50 -expressing mice compared with those of GFP-expressing mice at 3 months of age, whereas no significant difference was observed at 1 month of age ( fig. S4A ). Transcript levels of CD68, a marker of activated microglia, were elevated at 1 and particularly 3 months of age in GFP-(PR) 50 mice ( fig. S4A ). Similar to RNA levels of Gfap and CD68, Gfap and CD68 protein expression in the cortices and cerebellums of 3-month-old GFP-(PR) 50 mice increased significantly, as confirmed by immunohistochemical analysis ( fig. S4 , B to E).
Examination of c9FTD/ALS behavioral features in 3-month-old GFP-or GFP-(PR) 50 -expressing mice revealed both motor and cognitive deficits in the latter group (Fig. 1, F 50 mice exhibited a decreased latency to fall compared with GFP mice (Fig. 1F ), indicating impaired motor skills. GFP-(PR) 50 mice also displayed an associative memory deficit, as evidenced by a decrease in cued, but not contextual, freezing in a fear-conditioning task (Fig. 1G ).
and G). On the rotarod test, GFP-(PR)

Poly(PR) proteins localized to heterochromatin and elicited aberrant posttranslational modifications of histone H3
Previous studies reported that poly(PR) causes cell death by accumulating in the nucleoli of cultured cells and neurons (23, 24, 26, 30) . Our GFP-(PR) 50 -expressing mice provided an opportunity to investigate the mechanisms that underlie poly(PR)-induced neurotoxicity in vivo. We began by examining the cellular localization of poly(PR) in the brains of mice and found it to be present in a punctate pattern throughout the nucleus ( Fig.  2A) . Whereas some GFP-(PR) 50 colocalized with the nucleolar markers nucleophosmin (NPM1) and fibrillarin ( Fig. 2A) , the majority of GFP-(PR) 50 formed punctate structures that colocalized with the DNA-staining dye Hoechst 33258, suggestive of a heterochromatic distribution of poly(PR). Immunoelectron microscopy revealed that antipoly(PR) antibodies decorated heterochromatin in the cortices of 3-month-old GFP-(PR) 50 mice ( Fig. 2B ) and purified mouse genomic DNA incubated with synthetic (PR) 8 peptides (Fig. 2C) . Furthermore, electron microscopy showed that incubating genomic DNA with (PR) 8 or (GR) 8 peptides, but not (GA) 8 , (GP) 8 , or (PA) 8 peptides, changed DNA morphology, suggesting an electrostatic interaction between the negatively charged DNA and the positively charged (PR) 8 and (GR) 8 ( Fig. 2C and fig. S5A ). Electrophoretic mobility 50 mice at 1 month (1M) (n = 8 mice) and 3 months (3M) (n = 10 mice) of age. Scale bars, 100 mm. (C) An immunoassay was used to compare poly(PR) levels in cortex and hippocampus lysates of GFP-(PR) 50 mice at 1 (n = 8 mice) and 3 (n = 9 mice) months of age. (D) Representative images of NeuN-labeled cells in the cortices of 3-month-old GFP or GFP-(PR) 50 mice. Scale bars, 100 mm. (E) Quantification of NeuN-labeled cells in the cortices of GFP mice at 1 (n = 8 mice) and 3 (n = 10 mice) months of age or GFP-(PR) 50 mice at 1 (n = 8 mice) and 3 (n = 10 mice) months of age. (F) Results from a 4-day rotarod test used to assess motor deficits of 3-month-old mice expressing GFP (n = 12 mice) or GFP-(PR) 50 (n = 11 mice) by evaluating their latency to fall from a rotating rod. (G) Results from the fear-conditioning test used to assess the associative learning and memory of 3-month-old mice expressing GFP (n = 12 mice) or GFP-(PR) 50 (n = 11 mice) by evaluating the percentage of time frozen in response to a conditioned (cued) or unconditioned (context) stimulus. Data are presented as the mean ± SEM. Male mice are represented by solid symbols, whereas female mice are represented by empty symbols. In (B) and (C), ****P < 0.0001, **P = 0.0072, two-tailed unpaired t test. In (E), ****P < 0.0001; NS (not significant), P = 0.1130; two-way ANOVA and Tukey's post hoc analysis. In (F), NS, P = 0.1269; **P = 0.0096; ##P = 0.0015; ***P = 0.0005; two-way ANOVA and Tukey's post hoc analysis. In (G), ****P < 0.0001; NS, P = 0.6007; two-tailed unpaired t test.
shift assays also demonstrated that single-and double-stranded DNA bound to (PR) 20 and (PR) 8 peptides, thus forming higher-molecular-weight, less mobile complexes that were not observed when DNA was incubated with (PA) 8 peptides ( Fig. 2D and fig. S5B ).
To confirm that poly(PR) localized to heterochromatin in mice, cortical sections from 3-monthold GFP-(PR) 50 mice were co-stained for poly(PR) and the heterochromatin markers histone H3 lysine 9 trimethylation (H3K9me3) and histone H3 lysine 27 trimethylation (H3K27me3) or the euchromatin marker histone H3 lysine 4 trimethylation (H3K4me3) (Fig. 2E and fig. S5 , C and D). These studies established that GFP-(PR) 50 essentially completely colocalized with heterochromatin markers (Fig. 2E and fig. S5C ). Whereas the euchromatin marker H3K4me3 expectedly failed to colocalize with Hoechst 33258-stained heterochromatin in poly(PR)-negative cells, it did colocalize with heterochromatin and poly (PR) in GFP-(PR) 50 -positive cells (Fig. 2E and  fig. S5D ). Moreover, levels of both the transcriptionally repressive H3K27me3 and the transcriptionally active H3K4me3 were increased in cells expressing poly(PR) compared with poly(PR)-negative cells in mice expressing GFP-(PR) 50 or GFP, and this was especially apparent for Hoechst 33258-stained pericentromeric heterochromatin ( fig. S5, C to F) . These data suggest that poly(PR) influences histone H3 posttranslational modifications. As in GFP-(PR) 50 mice, poly(PR) colocalized with H3K27me3 and H3K4me3 in the cortices of c9FTD/ALS patients (Fig. 2F, fig. S5G , and table S1). In fact, all nuclear poly(PR) inclusions detected in the cortices of patients with c9FTD/ALS colocalized with H3K27me3 and H3K4me3.
Poly(PR) proteins caused nuclear lamina invaginations, reduced HP1a protein expression, and disrupted HP1a liquid phases Next, we investigated the influence of poly(PR) on heterochromatin structure by examining the lamins and heterochromatin protein 1a (HP1a), key proteins in establishing and maintaining heterochromatin structure (35) (36) (37) (38) . Staining of mouse brain sections for lamins A/C and B showed a significantly higher frequency of nuclear lamina invaginations in cells expressing poly(PR) than in poly(PR)-negative cells in mice expressing GFP-(PR) 50 or GFP (Fig. 3A and fig. S6A ). Moreover, we noted that cells expressing poly(PR) showed markedly decreased expression of HP1a protein ( Fig. 3B and fig. S6B ) but not HP1a mRNA ( fig. S6C ). Rather, a modest increase in HP1a mRNA was observed, which may reflect a compensatory mechanism. By contrast to HP1a, HP1b remained unchanged in poly(PR)-positive cells ( fig. S6D ). Despite the finding that (GR) 8 , like (PR) 8 , changed DNA morphology in vitro ( fig. S5A ), HP1a protein levels were not altered in GFP-(GR) 100 mice ( fig. S6E ), nor does poly(GR) influence lamin distribution in mice (39) . Because poly(GR) does not localize to the nucleus, these data suggest that poly(PR)-induced alterations of lamins and HP1a are caused by the heterochromatic distribution of poly(PR) within the nucleus.
Poly(PR) may cause decreases in HP1a by impairing lamin function (40) (41) (42) and may also influence HP1a more directly, given that both poly(PR) and HP1a localize to heterochromatin. HP1a undergoes liquid-liquid phase separation (LLPS), with liquid HP1a compartments sequestering compacted chromatin and promoting heterochromatin-mediated gene silencing (43, 44) . Poly(PR) interferes with the LLPS of RNA binding proteins with prionlike domains and promotes aberrant phase transitions from liquid droplets to solid aggregates (26) . Thus, we examined whether poly(PR) disrupted preformed HP1a liquid droplets in vitro to mimic in vivo conditions Zhang when poly(PR) encounters liquid HP1a compartments on heterochromatin. We first assembled HP1a droplets, spherical structures that readily underwent fusion consistent with liquidlike properties (Fig. 3C, arrow) . To these HP1a liquid droplets, we added (PR) 8 , which under these conditions did not phase separate in isolation (Fig. 3C) . Initially, (PR) 8 rapidly induced the formation of solid components (Fig. 3D , blue arrows), which were not observed before the addition of (PR) 8 (Fig. 3C) , inside the HP1a liquid droplets. HP1a droplets then violently burst to release these solid components (Fig. 3D , black arrows, and movie S1). After incubation with (PR) 8 , few HP1a droplets remained (Fig. 3D) . By contrast, (PA) 8 had no effect on preformed HP1a liquid droplets ( Fig. 3E and movie S2 ). Thus, (PR) 8 but not (PA) 8 rapidly elicited an aberrant phase transition within HP1a droplets and caused their rupture. We suggest that this mechanism directly disrupts HP1a liquid compartments on heterochromatin, thereby evicting and depleting HP1a from heterochromatin, where it is replaced by poly(PR) in vivo.
Poly(PR) enhanced repetitive element expression and caused the accumulation of double-stranded RNA Given that poly(PR) elicited aberrant posttranslational modifications of histone H3 and caused lamin invagination and decreases in HP1a protein, which are expected to influence gene expression, we compared transcriptome profiles between 3-month-old mice expressing GFP or GFP-(PR) 50 . Clustering of the 1000 most variable genes showed distinct expression profiles for GFP-(PR) 50 and GFP mice (Fig. 4A) . Of the 2196 genes that were differentially expressed in GFP-(PR) 50 mice, the majority (1552) were downregulated ( Fig. 4B and dataset S1 ). Weighted gene coexpression network analysis of differentially expressed genes with a merging distance of 0.01 identified 13 modules, all of which were significantly associated with genotype after adjustment for multiple tests ( Fig. 4C and dataset S1). Gene Ontology enrichment analysis across these modules identified the pink and blue modules as the most significantly enriched. Within the pink module, molecular function and biological process analyses, respectively, identified top terms specific to unfolded protein binding (P = 2.13 × 10 −8
; Bonferroni correction = 8.77 × 10 −5 ) and protein folding (P = 3.05 × 10 −9 ; Bonferroni correction = 3.63 × 10
−5
). Within the blue module, molecular function, cellular component, and biological process analyses, respectively, identified top terms specific to the structural constituent of the ribosome (P = 9.26 × 10 ; Bonferroni correction = 3.75 × 10 −3 ). These pathways have been implicated in c9FTD/ALS (26, 31, 39, 45, 46) .
In addition to identifying differentially expressed genes in GFP-(PR) 50 mice, we examined the expression of repetitive elements (REs) given our findings that poly(PR) localized to heterochromatin and that repetitive DNA sequences, which make up a large portion of heterochromatin (47) , are significantly up-regulated in the brains of patients with c9ALS (48) . By using a combination of RepEnrich2 and DESeq2, we identified a total of 1067 RepeatMasker-derived REs belonging to multiple repeat classes (dataset S2). Notably, the proportions of REs in distinct classes were comparable among GFP, GFP-(PR) 50 , and GFP-(GR) 100 mice (table S2). In GFP-(PR) 50 mice compared with control GFP mice, 172 REs were differentially expressed [false discovery rate (FDR) < 0.10], with~92% of these being upregulated (Fig. 5A ). This marked up-regulation of REs contrasted with the down-regulation of the majority of differentially expressed genes (Fig. 4B) . Quantitative polymerase chain reaction (qPCR) analysis of select RE hits confirmed their up-regulation (Fig. 5B and fig. S7A ). No specific classes of REs were enriched, indicating a global change in their expression. Of note, no RE was differentially expressed in mice expressing GFP-(GR) 100 (fig. S7B ). Because RE transcripts were elevated in GFP-(PR) 50 mice and because these transcripts can form double-stranded RNA (dsRNA) (49-51), we evaluated whether dsRNA was produced in GFP-(PR) 50 mice. Immunofluorescence staining with an antibody against dsRNA revealed that dsRNA was specifically increased in cells expressing poly(PR) (Fig. 5C and fig. S7C ). Accumulation of dsRNA was not observed in mice expressing GFP-(GR) 100 (fig. S7D) .
A previous study found that the deletion of HPL-2, a Caenorhabditis elegans ortholog of HP1a, leads to the accumulation of dsRNA (52) . To further determine whether the reduction of HP1a in GFP-(PR) 50 mice contributed to the observed accumulation of dsRNA, we repressed HP1a transcription in human cells by CRISPR interference 4 of 9 50 and lamin A/C or lamin B in the cortices of 3-month-old GFP (n = 11) or GFP-(PR) 50 (n = 7) mice. Scale bars, 10 mm. (B) Double immunofluorescence staining for GFP-(PR) 50 and HP1a in the cortices of 3-month-old GFP-(PR) 50 mice (n = 7). Scale bars, 5 mm. (C) Differential interference contrast (DIC) microscopy images of HP1a droplets at a concentration of 90 mM HP1a before the addition of (PR) 8 . The arrow indicates the fusing of two liquid droplets. By contrast, (PR) 8 peptides at a concentration of 245 mM did not form droplets under these conditions. (D) DIC microscopy images of HP1a droplets at 90 mM HP1a (top, low magnification; bottom, high magnification) after the addition of 245 mM (PR) 8 . Black arrows indicate the bursting of a preformed HP1a droplet after the addition of (PR) 8 . Small blue arrows indicate the solid components within HP1a droplets. (E) DIC microscopy images of HP1a droplets at 90 mM HP1a (top, low magnification; bottom, high magnification) after the addition of 245 mM (PA) 8 peptides. In (D) and (E), turquoise arrows between images indicate progression over time.
(CRISPRi), which is highly specific compared with RNA interference-based approaches (53, 54) . To this end, we individually transduced human induced pluripotent stem cells (iPSCs) stably expressing nuclease-deactivated CRISPR-associated protein 9 fused to blue fluorescent protein and the KRAB repressor domain (dCas9-BFP-KRAB) (55) with five single guide RNAs (sgRNAs) predicted to mediate CRISPRi of the HP1a gene. Because sgRNA 1 had the greatest ability to decrease HP1a protein expression ( fig. S7E ), we differentiated dCas9-BFP-KRAB iPSC cells expressing HP1a sgRNA 1 into neurons. HP1a sgRNA 1 caused a~40% reduction of HP1a RNA, as assessed by qPCR ( fig. S7F) . Notably, dsRNA accumulated only in iPSC-differentiated neurons depleted of HP1a (Fig. 5D) . Moreover, cells positive for dsRNA showed immunoreactivity for active caspase-3 (Fig. 5E ), suggesting that dsRNA is toxic to neurons.
Poly(PR) caused abnormalities in nucleocytoplasmic transport proteins
Earlier studies have demonstrated that poly(PR) aberrantly affects nuclear pores and impairs nucleocytoplasmic transport in cultured cells and yeast models (27, 28) . Because poly(PR) caused lamin invagination in poly(PR) mice (Fig. 3A and  fig. S6A ), which may affect nuclear membrane integrity, we investigated whether poly(PR) also perturbs the nucleocytoplasmic transport factor Ran guanosine triphosphatase-activating protein 1 (RanGAP1) and nuclear pore complex (NPC) proteins, the latter assessed by using an antibody that recognizes Phe-x-Phe-Gly (where x is usually a small residue such as Ser, Gly, or Ala) nucleoporin repeats. We observed abnormal nuclear membrane invaginations immunopositive for RanGAP1 or NPC proteins in poly(PR)-positive cells compared with poly(PR)-negative cells in mice expressing GFP-(PR) 50 or GFP (Fig. 6 and fig. S8A ). RanGAP1 was abnormally distributed in virtually all poly (PR)-positive cells (Fig. 6A and fig. S8A ), whereas NPC protein abnormalities in poly(PR)-positive cells were less frequent (Fig. 6B) .
Given that defects in RanGAP1 may impair the nucleocytoplasmic transport of TDP-43 and promote its cytoplasmic accumulation, we evaluated whether poly(PR) caused TDP-43 pathology, a hallmark feature of c9FTD/ALS. However, similar to mice expressing poly(GA) or poly(GR) (39, 56) , poly(PR)-expressing mice did not develop TDP-43 inclusions, suggesting that the expression of individual DPR proteins is insufficient to cause TDP-43 pathology within the time frames examined (Fig. 6C and fig. S8B ). Additional pathological mechanisms associated with poly(PR) include stress granule formation and nucleolar stress (23, 24, 26, 30) . Nevertheless, no evidence of stress granules was seen in the brains of GFP-(PR) 50 mice ( fig. S8C ). This may be due to the absence of cytoplasmic poly(PR) inclusions, which, similar to poly(GR) cytoplasmic inclusions, have been shown to initiate stress granule formation and sequester stress granule-associated proteins (26, 39) . Likewise, although nucleolar poly(PR) was occasionally observed in GFP-(PR) 50 mice, no sign of nucleolar stress (i.e., repressed ribosomal RNA expression) was detected ( fig. S8, D and E) , suggesting that nucleolar poly(PR) levels must reach a threshold to induce nucleolar stress.
Discussion
In this study, we found that poly(PR) expression in the brain caused premature death in~60% of mice, with surviving GFP-(PR) 50 mice developing age-dependent brain atrophy and neuron loss, as well as impaired motor and memory functions. GFP-(PR) 50 mice that succumbed to an early death exhibited higher poly(PR) levels than surviving mice (37.89 ± 11.88 versus 23.99 ± 7.071 ng/ mg; P = 0.0367, two-tailed unpaired t test), indicative that poly(PR) toxicity is dose dependent. The age-dependent neuron loss in surviving mice was accompanied by a similar age-dependent loss of poly(PR)-positive cells, suggesting that poly(PR)-positive neurons progressively degenerated. These data are consistent with the results of a study showing that poly(PR) expression causes cultured neurons to die in a time-dependent fashion (24) and may also explain, at least in part, why poly(PR) pathology is rare in postmortem brain tissues from c9FTD/ALS patients (19, 20, 33, 34) , which reflect the end stage of disease.
The neurodegeneration and behavioral deficits of GFP-(PR) 50 mice were associated with the localization of poly(PR) to heterochromatin, highly condensed regions of transcriptionally silent chromatin (47) . A heterochromatic localization of poly(PR) was also observed in c9FTD/ALS patients. Both increased H3K27me3, which represses gene expression, and increased H3K4me3, which activates gene expression, were observed in the heterochromatin of poly(PR)-expressing cells. Although the mechanism(s) by which poly(PR) elicited aberrant posttranslational modifications of histone H3 remain to be determined, these data suggest that poly(PR) causes epigenetic changes, which may influence heterochromatin function in c9FTD/ALS. Our RNA-sequencing (RNA-seq) and qPCR analyses of GFP-(PR) 50 mouse brain tissues revealed that RE sequences, which are enriched in heterochromatin DNA, were significantly up-regulated. Poly(PR)-induced RE expression in cultured cells was also evident through the accumulation of dsRNA, which can be formed by REs (49) (50) (51) . The expression of REs, which is observed in several neurodegenerative diseases, is associated with neurotoxicity (49, 57, 58) . Increased RE expression (48) and dsRNA accumulation (57) occur in c9FTD/ALS patients, and we reported previously that increases in general transcription may contribute to this enhanced RE expression (48) . It is thus noteworthy that despite the marked up-regulation of REs in GFP-(PR) 50 mice, the majority of differentially expressed genes were down-regulated. Therefore, data from our GFP-(PR) 50 mice suggest that poly(PR) plays a role in RE expression in c9FTD/ALS but does so through heterochromatin alterations rather than enhanced transcription.
To more thoroughly evaluate how poly(PR) causes abnormal RE expression, we investigated lamins and HP1a, key proteins in establishing and maintaining heterochromatin structure and in regulating gene silencing (35) (36) (37) (38) . Lamin dysfunction and/or loss of HP1a causes heterochromatin relaxation and mitigates gene silencing, which result in the increased expression of DNA REs within heterochromatin regions (35) (36) (37) (38) . It is thus of interest that the localization of poly(PR) to heterochromatin coincided with lamin invaginations and decreased HP1a expression in the brains of GFP-(PR) 50 mice. Whereas poly(PR) may cause HP1a depletion indirectly by inducing lamin dysfunction (40) (41) (42) , it may also directly disrupt HP1a liquid compartments on heterochromatin, thereby evicting HP1a and rendering it vulnerable to degradation. Our data raise the following possible scenario: poly(PR) ruptures HP1a liquid phases on heterochromatin, interacts directly with DNA, and accumulates on heterochromatin. In turn, the disruption of HP1a liquid phases leads to lamin invaginations and HP1a depletion, which cause increased RE expression and dsRNA accumulation. In support of this, we confirmed that the knockdown of HP1a in human iPSC-differentiated neurons resulted not only in the accumulation of dsRNA but also in caspase-3 activation, a marker of apoptosis. Although further studies are needed to delineate the precise mechanism by which poly(PR) causes lamin invaginations, one potential cause or consequence is defects in nucleocytoplasmic transport proteins, which have previously been implicated in c9FTD/ALS (15, 28, 56) . We observed that RanGAP1 was abnormally distributed in all poly(PR)-positive cells in GFP-(PR) 50 mice, and NPC protein abnormalities were also found, albeit less frequently. The exact contribution of these phenomena to the neurodegeneration and behavioral deficits of GFP-(PR) 50 mice remains to be resolved.
Overall, our studies provide compelling evidence that, by interacting with DNA, eliciting aberrant histone posttranslational modifications, and disrupting HP1a liquid phases, poly(PR) adversely influences heterochromatin structural organization. Consequently, RE expression is induced and dsRNA accumulates, contributing to the neurodegeneration seen in patients with c9FTD/ALS. Rescuing histone methylation, lamin, and HP1a abnormalities and/or inhibiting the abnormal expression of REs may represent promising therapeutic strategies for treating c9FTD/ALS.
Materials and methods summary
Detailed materials and methods can be found in the supplementary materials.
Generation of plasmids
To generate the AAV-GFP-(PR) 50 plasmid, a pEGFP-C1-(PR) 50 plasmid produced in our previous study (59) was subcloned into a modified AAV packaging vector containing the cytomegalovirus (CMV)-enhanced chicken b-actin promoter and the enhanced GFP (EGFP) coding sequence. To generate the HP1a-His plasmid, cDNA of an HP1a fragment was ligated to the NdeI and XhoI restriction sites of a pET-30a vector (69909-3, EMD Millipore). To generate Lenti-HP1a-sgRNA plasmids, we chose five sgRNA sequences against HP1a (CBX5) described in a previous study (60) . The forward and reverse oligonucleotides were annealed and then ligated to the BstXI and BlpI restriction sites of a pU6-sgRNA EF1Alpha-puro-T2A-BFP vector (53) . The sequence of GFP-(PR) 50 and primer sequences for cloning are listed in tables S3 and S4, respectively.
Virus production
To produce recombinant AAV1 (rAAV1) virus, AAV vectors expressing GFP or GFP-(PR) 50 were cotransfected with helper plasmids in human embryonic kidney (HEK) 293T cells. Cells were harvested 72 hours after transfection and lysed in the presence of 0.5% sodium deoxycholate (SDS) by freeze thawing, and the virus was isolated by using a discontinuous iodixanol gradient. The genomic titer of each virus was determined by qPCR. To produce lentivirus, HEK293T cells were cotransfected with plasmids of HP1a-sgRNA, psPAX2 (12260, Addgene), pMD2.G (12259, Addgene), and pAdVAntage (E1711, Promega) by using Lipofectamine 2000 (11668-019, Thermo Fisher Scientific). Media containing virus were harvested, filtered, and used to transduce dCas9-iPSCs.
Approvals
All procedures using mice were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (61) and approved by the Mayo Clinic Institutional Animal Care and Use Committee (protocol number A42014).
Neonatal viral injections
Intracerebroventricular injections of virus in postnatal-day-0 C57BL/6J pups were performed as previously described by using 2 ml (1 × 10 10 genomes/ml) of AAV1-GFP or AAV1-GFP-(PR) 50 solution per cerebral ventricle (39, 56). 
Behavioral tests
Three-month-old mice expressing GFP (n = 12 mice) or GFP-(PR) 50 (n = 11 mice) were subjected to behavioral analysis in two consecutive weeks by the Mayo Mouse Behavior Core. On two consecutive days of week 1, mice were subjected to tests of contextual and cued fear conditioning. On four consecutive days of week 2, the mice were subjected to the rotarod test. A detailed description of these tests is provided in the supplementary materials.
Tissue processing
For RNA, protein, and immunostaining analyses, mice were euthanized by CO 2 and brains were harvested and cut sagittally across the midline. Sagittal half brains were immersion fixed in 10% formalin, embedded in paraffin, sectioned (to 5 mm thick), and mounted on glass. The cortex and hippocampus of the other half brain were dissected and frozen on dry ice. Frozen mouse cortex and hippocampus tissues were homogenized in ice-cold tris-EDTA (TE), pH 8.0, with 2× protease and phosphatase inhibitors. Homogenates were used for RNA or protein extractions. For immunoelectron microscopy studies, mice were anesthetized with sodium ketamine and xylazine and then perfused with 0.9% saline followed by 4% paraformaldehyde. Brains were harvested, cut sagittally across the midline, and placed in 4% paraformaldehyde.
Preparation of brain protein lysates
To prepare protein lysates, 10% Triton X-100 and 10% SDS were added to brain homogenates at final concentrations of 1% and 2%, respectively. Homogenates were sonicated on ice and then centrifuged at 16,000 × g for 20 min. Supernatants were collected as lysates, and protein concentrations were determined by a bicinchoninic acid (BCA) assay (23225, Thermo Fisher Scientific). Protein lysates were used for Western blot and immunoassay analyses as described in the supplementary materials by using antibodies listed in table S5.
Human tissues
Postmortem frontal cortical tissues from FTD and ALS patients with C9orf72 repeat expansions were obtained from the Mayo Clinic Florida Brain Bank. Information on human patients is provided in table S1. Written informed consent was obtained from all subjects or their legal next of kin if they were unable to give written consent, and biological samples were obtained with Mayo Clinic Institutional Review Board approval.
Immunohistochemistry and immunofluorescence staining
Paraffin sections of mouse and human brains were subjected to immunohistochemistry and immunofluorescence staining as previously described (39, 56) . Detailed methods for staining conditions, information on primary antibodies used, and quantification of neuropathology are provided in the supplementary materials and table S5.
Electrophoretic mobility shift assays
To analyze the binding of (PR) 20 , (PR) 8 , or (PA) 8 to single-or double-stranded DNA, Cy3-labeled random, CG-rich, or AT-rich oligonucleotides were incubated with the peptides before samples were resolved on 4 to 20% tris-borate EDTA (TBE) gels (Invitrogen) as described in the supplementary materials.
Postembedding immunoelectron microscopy
To examine the localization of poly(PR) proteins in mouse brain, immunoelectron microscopy was performed (56, 59 RNA-seq, Gene Ontology, and repetitive element analyses
The library preparation and RNA-seq were performed by the Mayo Clinic Sequencing Core Facility (Rochester, MN) as previously described (39) and as detailed in the supplementary materials. After the preparation of the libraries, samples were subjected to quality control, cluster generation, and sequencing on the Illumina HiSeq 2000 platform. All reads had a read length of 100 bp and were paired-end. The number of reads per sample is listed in table S7. Weighted gene coexpression network analysis, the Gene Ontology overrepresentation test, differential expression analysis, and RE analysis were performed as described in the supplementary materials.
Purification of recombinant HP1a proteins
HP1a-His plasmid was used for transformation in Rosetta(DE3)pLysS competent cells (709563, EMD4Biosciences). To induce the expression of recombinant proteins, bacteria were cultured overnight at 16°C in the presence of 0.5 mM isopropyl b-D-1-thiogalactopyranoside. After centrifugation, the bacterial pellet was washed, lysed, sonicated, and centrifuged. The resulting supernatant was applied to a HisTrap HP histidinetagged protein purification column (17524801, 7 of 9 50 and RanGAP1 in the cortices of 3-month-old GFP (n = 11) or GFP-(PR) 50 (n = 7) mice. Scale bars, 5 mm. (B) Double immunofluorescence staining for GFP-(PR) 50 and NPC proteins in the cortices of 3-month-old GFP or GFP-(PR) 50 mice (n = 4 mice per group). Scale bars, 5 mm. Insets in (A) and (B) show boxed areas at higher magnification. (C) Double immunofluorescence staining for GFP-(PR) 50 and TDP-43 in the cortices of 3-month-old GFP or GFP-(PR) 50 mice (n = 3 mice per group). Scale bars, 5 mm.
GE Healthcare), and the recombinant proteins were eluted, desalted, and concentrated.
In vitro DPR protein and HP1a assays
HP1a liquid droplets (90 mM monomer) were formed in buffer containing 50 mM tris, pH 7.5. The preformed HP1a droplets were spotted onto a coverslip and imaged for 5 min, and then 245 mM (PR) 8 or (PA) 8 peptides were added to the sample and the sample was imaged for another 5 to 10 min. We modified a well-characterized control iPSC line (WTC11) that harbors a dox-inducible NGN2 transgene at the AAVS1 locus (i 3 N) (62, 63) . dCas9-BFP-KRAB was stably expressed in these i 3 N iPSCs via TALEN-mediated integration of a CAG-dCas9-BFP-KRAB expression cassette into the CLYBL safe harbor locus (55) . The dCas9-BFP-KRAB iPSCs were transduced with lentivirus expressing HP1a-sgRNA for 3 days and then selected by the addition of puromycin. To differentiate i 3 N dCas9-BFP-KRAB iPSCs expressing HP1a sgRNA into neurons, iPSCs were dissociated by using Accutase (#AT-104, Innovative Cell Technologies) and then seeded onto dishes coated with Matrigel (354230, Corning). Three days after differentiation, cells were dissociated by using Accutase and then seeded onto poly-L-ornithine-coated plates (6-well plate) or glass coverslips (24-well plate) at a density of 7 × 10 5 or 2 × 10 4 cells per well, respectively. Six days later, the neurons were fixed with 4% paraformaldehyde for immunofluorescence staining or harvested for Western blot and qPCR analyses.
Statistics
Data are presented as the mean ± the standard error of the mean (SEM) and analyzed with a two-tailed unpaired t test or one-way or two-way analysis of variance (ANOVA) followed by Tukey's post hoc analysis (Prism statistical software). End points of interest [i.e., body weight, brain weight, poly(PR)-positive cells, poly(PR) expression, NeuNpositive cortical neurons, Purkinje cell density, transgene RNA levels, Gfap and CD68 mRNA expression, and Gfap and CD68 immunopositivity] were compared between male and female mice within each cohort. Other than body weight, no sex differences were observed. With the exception of body weight, analyses were performed on all mice within a given cohort. Data are presented such as to distinguish male and female mice; male mice are represented by solid symbols on dot plots, and female mice by empty symbols. Statistical analysis of RNA-seq data is described in the section RNA-seq, Gene Ontology, and RE analyses.
